## CPB: The Campbell's Company - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 0.69 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($28.20)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Bearish (Bullish: 0, Bearish: 2)

**1. ‘Sh-t for Poor People’: Campbell Soup VP Caught Spewing Racial Views About Co-workers in Voice Recording That’s Prompted Boycott, Piping-Hot Lawsuit**
- Source: Atlanta Black Star | 20251203T172144 | Bearish | Relevance: 100%
- A Campbell Soup Company executive, Martin Bally, is facing a lawsuit after a whistleblower employee, Robert Garza, secretly recorded him making disparaging comments about the company's products, customers, and Indian colleagues. Garza, a security analyst, claims he was fired shortly after reporting Bally's remarks to management. The lawsuit accuses Campbell Soup Company of maintaining a racially hostile work environment and retaliating against Garza, prompting public outcry and a boycott threat against the company.

**2. Rep. Neyer: Campbell’s Soup controversy highlights need for lab-grown meat labeling**
- Source: Michigan House Republicans | 20251205T110752 | Bearish | Relevance: 100%
- State Rep. Jerry Neyer is advocating for mandatory clear labeling on lab-grown meat products, citing a controversy at Campbell's Soup Company where an executive was fired for claiming the company uses bioengineered meat. Neyer's House Bill 4076, designed to implement these labeling requirements, has already passed the House with substantial support. He emphasizes that such regulations would protect consumers and ensure transparency regarding food ingredients.

**3. HORMEL FOODS REPORTS FOURTH QUARTER AND FULL-YEAR FISCAL 2025 RESULTS**
- Source: KWKT - FOX 44 | 20251204T110847 | Neutral | Relevance: 59%
- Hormel Foods Corporation has reported its fourth-quarter and full-year fiscal 2025 results, with net sales reaching $12.1 billion for the full year, a 1.6% increase. Despite top-line growth driven by brand relevance, profitability was challenged by input cost inflation and non-cash impairment charges. The company projects net sales of $12.2 billion to $12.5 billion for fiscal 2026, anticipating improved earnings performance and continued dividend increases.

**4. Macom Technology Solutions stock hits all-time high at 179.42 USD**
- Source: Investing.com | 20251203T080957 | Somewhat-Bearish | Relevance: 58%
- Macom Technology Solutions (MTSI) stock reached an all-time high of $179.42, reflecting robust market performance with significant year-to-date and six-month gains. Despite not being profitable in the last twelve months, analysts expect profitability in FY2026, with a projected EPS of $4.28. The company recently reported strong Q4 2025 earnings, leading to increased price targets from Needham and Truist Securities.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Morgan Stanley | $30 | $33 | -9% |
| 2025-12-04 | UBS | $28 | $30 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Morgan Stanley | main | Equal-Weight |
| 2025-12-04 | UBS | main | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.00M) |
| Sells | 9 ($1.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Blackrock Inc.: 8.5% (+6.3%)
- Vanguard Group Inc: 7.9% (-2.2%)
- State Street Corpora: 3.7% (-7.1%)
- Invesco Ltd.: 2.7% (+42.6%)
- Beutel, Goodman & Co: 2.3% (-11.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.2% 5d) with bearish MACD, trend may be turning.
2. High short interest (18.8%, 3.9 days to cover): squeeze risk or crowded bearish bet.
3. Long-term trend broken: trading 12.4% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($1.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.4B |
| Beta | -0.06 |
| 52W Range | $27.64 - $43.85 |
| Short Interest | 18.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 11.3 |
| Current P/E | 12.2 |
| YoY Growth | 7.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.4% to -5.6% (-4.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.6pp (needs >4.0% for momentum thesis). AM_20 at -3.4% indicates price below own 20MA trend. Underperforming sector by 4.2pp, stock-specific weakness. Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 40. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.60% (CS: 9) | Weak |
| RSI_14 | 40.1 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 0.876x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $29.60
- **Stop Loss:** $28.20 (4.7% risk)
- **Target:** $32.40 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $10,567.20
- **Portfolio %:** 10.57%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.73 | $0.77 | +5.0% |
| 2025Q3 | $0.57 | $0.62 | +9.0% |
| 2025Q2 | $0.66 | $0.73 | +11.4% |
| 2025Q1 | $0.72 | $0.74 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*